1448867-42-2 Usage
Uses
Used in Pharmaceutical Industry:
(R)-5-(5-chloro-1-methyl-2-oxo-1,2-dihydro-pyridin-3-yl)-6-(4-chloro-phenyl)-2-(2,4-dimethoxy-pyrimidin-5-yl)-1-isopropyl-5,6-dihydro-1H-pyrrolo[3,4-d]imidazol-4-one is used as a potential drug candidate due to its complex structure and various functional groups, which may exhibit biological activity and be relevant for the development of new medications.
Used in Chemical Biology Studies:
In the field of chemical biology, (R)-5-(5-chloro-1-methyl-2-oxo-1,2-dihydro-pyridin-3-yl)-6-(4-chloro-phenyl)-2-(2,4-dimethoxy-pyrimidin-5-yl)-1-isopropyl-5,6-dihydro-1H-pyrrolo[3,4-d]imidazol-4-one serves as a tool compound for investigating the interactions between small molecules and biological targets, potentially leading to a better understanding of disease mechanisms and the discovery of novel therapeutic strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 1448867-42-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,8,8,6 and 7 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1448867-42:
(9*1)+(8*4)+(7*4)+(6*8)+(5*8)+(4*6)+(3*7)+(2*4)+(1*2)=212
212 % 10 = 2
So 1448867-42-2 is a valid CAS Registry Number.
1448867-42-2Relevant academic research and scientific papers
CHEMICAL PROCESS FOR PREPARING IMIDAZOPYRROLIDINONE DERIVATIVES AND INTERMEDIATES THEREOF
-
, (2018/06/12)
The present disclosure relates to a method of synthesizing imidazopyrrolidinone derivative, such as compound of formula (I), or a solvate including hydrate thereof, or a co-crystal thereof, and/or intermediates thereof, their use as pharmaceuticals and the use of intermediates.
IMIDAZOPYRROLIDINONE COMPOUNDS
-
, (2013/08/15)
The invention relates to compounds of formula (I): (I) as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.
